Drug intelligence / Profile preview

Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center

Development stage
Preclinical
Lead developer
Tel Aviv Sourasky Medical Center
Modality
Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center refers to a Hepatitis B vaccine utilized in clinical research at the Tel-Aviv Sourasky Medical Center to investigate the relationship between the mesolimbic reward system and immune functioning. In this context, the vaccine serves as a biological probe to assess how neuromodulation, specifically via fMRI neurofeedback, can influence the human immune response. Standard Hepatitis B vaccines are typically composed of recombinant Hepatitis B surface antigen (HBsAg), which stimulates the production of protective antibodies (anti-HBs) to provide active immunity against the Hepatitis B virus (HBV). The research at Sourasky Medical Center specifically monitors the antibody titers following vaccination as a quantitative measure of immune system efficacy in response to behavioral interventions.

Other names
Hepatitis B vaccinationHepatitis B vaccine
02

Targets

HBsAg (Hepatitis B surface antigen)

Beyond the preview

Go deeper on Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis B vaccine-Tel-Aviv Sourasky Medical Center.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call